The Individual Therapy for Patients With Wilson's Disease

Status Recruiting

Clinical Trial Summary

Based on the genotype characteristics and genotype-phenotype-treatment prognosis data of Chinese WD patients, this study intends to further optimize the treatment regimen of Chinese WD patients and formulate individualized treatment regimens for each genotype, so as to further improve the prognosis of patients.

Clinical Trial Description

The purpose of the study is to evaluate treatment regimen efficacy based on different mutations, and Zinc treatment in presymptomatic WD patients. ;

Study Design

Related Conditions & MeSH terms

Wilson's Disease

Clinical Trial Details

NCT number	NCT03957720
Study type	Interventional
Source	Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact	Zhi-Ying Wu, MD&PhD
Phone	+86-571-87783569
Email	zhiyingwu@zju.edu.cn
Status	Recruiting
Phase	Early Phase 1
Start date	March 15, 2019
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04537377` - A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease	Phase 1/Phase 2
Not yet recruiting	`NCT06051734` - Early Detection of Cardiac Affection in Patients of Wilson's Disease
Active, not recruiting	`NCT02252380` - ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders	N/A
Completed	`NCT01874028` - A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients	Phase 1
Recruiting	`NCT05183165` - Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease	N/A
Completed	`NCT00212355` - Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.	Phase 3
Recruiting	`NCT05493605` - Cardiac Involvement in Wilson's Disease	N/A
Recruiting	`NCT05239858` - International Wilson's Disease Patient Registry (iWilson Registry)
Recruiting	`NCT04012658` - A Registered Cohort Study on Wilson's Disease
Completed	`NCT02552628` - WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)	N/A
Completed	`NCT06128954` - Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).	Phase 1
Recruiting	`NCT05305872` - Gandouling in the Treatment of Wilson's Disease	Phase 4
Recruiting	`NCT04212195` - Cohort Research on Wilson's Disease
Completed	`NCT01378182` - Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis	N/A